IMARC Group, a leading market research company, has recently releases report titled “Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global multiple sclerosis therapies market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How Big is the Multiple Sclerosis Therapies Market?
Report Attributes | Details |
Market Size in 2022 | US$ 25.8 Billion |
Market Forecast in 2028 | US$ 33.6 Billion |
Growth rate (2023 to 2028) | CAGR of 4.4% |
Base Year of the Analysis | 2023 |
Forecast Period | 2023-2028 |
What are Multiple Sclerosis Therapies?
Multiple sclerosis (MS) therapies involve the administration of injectable, infused and oral medicines, antidepressants, muscle relaxants, and physical therapy. They aid in slowing the progression of the disease and managing associated symptoms. Apart from this, they also help in controlling the heart rate and blood pressure and minimizing the frequency of relapses among patients.
Request for a Free PDF sample report: https://www.imarcgroup.com/multiple-sclerosis-therapies-market/requestsample
What Are the Growth Prospects and Trends in the Multiple Sclerosis Therapies Market?
At present, the increasing prevalence of relapsing-remitting and secondary progressive MS across the globe represents one of the primary factors driving the market. Besides this, governing agencies of numerous countries are launching campaigns to generate awareness about the available treatments. This, along with the technological advancements, such as the introduction of innovative immunomodulators, monoclonal bodies, interferons, and immunosuppressants for the effective treatment of MS, is creating a favourable market outlook. Other factors, including considerable improvements in the healthcare infrastructure, along with extensive research and development (RD) activities, are anticipated to stimulate the growth of the market.
Who Are the Key Players Operating in the Multiple Sclerosis Therapies Industry?
The report has also analysed the competitive landscape of the market with some of the key players.
- Abbvie Inc.
- Bayer Aktiengesellschaft
- Biogen Inc.
- Bristol-Myers Squibb Company
- Hoffmann-La Roche AG (Roche Holding AG)
- GlaxoSmithKline Plc
- Merck Co. Inc.
- Novartis AG
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
What is Included in Market Segmentation?
The report has categorized the market based on drug, drug type, route of administration and distribution channel.
Breakup by Drug:
- Immunomodulators
- Copaxone
- Avonex/Plegridy
- Gilneya
- Tysabri
- Betaseron/Extavia
- Tecifidera
- Rebif
- Ampyra
- Immunosuppressants
- Aubagio
- Lemtrada
- Ocrelizumab
- Zinbryta
Breakup by Drug Type:
- Biologic Drugs
- Small Molecule Drugs
Breakup by Route of Administration:
- Oral
- Injectable
- Intravenous
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
